Gavin Painter
Victoria University of Wellington, NZ, New Zealand
- This delegate is presenting an abstract at this event.

Professor Gavin Painter – The Ferrier Research Institute, Victoria University of Wellington. New Zealand
Professor Painter obtained his PhD in chemistry from the University of Otago in 1995 (synthetic methodology) which was followed by postdoctoral research at the University of Cambridge (the synthesis of inositol phospholipids for elucidation of PI3K pathways). Since joining the Ferrier Research Institute, University of Wellington in New Zealand his research laboratory has focused on the synthesis of lipid-based materials including phosphatidyl inositol mannosides, glycolipids, glycolipid-peptide conjugates and novel lipid nano-delivery vehicles for encapsulation of various vaccine components including RNA, peptides, glycolipids and various immune stimulates. His research group is currently focused on the development of mRNA-LNP vaccines for Malaria and Hepatitis B including the development of novel delivery vehicles.
Presentations this author is a contributor to:
Synthesis and antitumour activity of 6''-thio-6''-deoxy-α-galactosylceramide (#91)
4:00 PM
Benjamin Compton
Poster Listing
Synthetic glycolipid-peptide conjugate vaccines utilise NKT cell help in vivo for improved CD8+ T cell immune responses (#52)
6:56 PM
Taryn Osmond
Rapid Fire Talks II
An NKT cell-activating glycolipid-peptide conjugate vaccine enhances human anti-viral CD8+ T cell responses (#84)
4:00 PM
Astrid Authier-Hall
Poster Listing
A phase I dose escalation trial of immunisation with autologous dendritic cells pulsed with NY-ESO-1 peptide and α-galactosylceramide in patients with high-risk surgically resected stage II, III or IV melanoma (#100)
4:00 PM
Olivier Gasser
Poster Listing